DUBLIN, Jan. 24, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that the peer-reviewed Journal of Hand Surgery Global Open published Collagenase Clostridium Histolyticum for ...
The MarketWatch News Department was not involved in the creation of this content.-- This marks the first live procedure at AAHS, as well as a first for Keenova. -- Treatment takes ...
Campaign builds on the momentum of Endo's disease awareness efforts. Commercial features a real patient—who was an untreated patient in a prior Endo video series—and his wife, sharing their personal ...
Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX® (collagenase clostridium histolyticum, or CCH) will be shared at the American ...
September 17, 2009 — The US Food and Drug Administration (FDA)'s Arthritis Advisory Committee voted unanimously (12 to 0) yesterday to recommend approval of collagenase clostridium histolyticum ...
Consensus-based study findings among expert hand surgeons indicate that XIAFLEX ® (collagenase clostridium histolyticum) has a wide-ranging application for the appropriate treatment of Dupuytren's ...
In the coming months you may hear about a new drug for treating cellulite, called Xiaflex. The pharmaceutical manufacturer that makes it just began clinical trials of its effects in January. I am not ...
A disabling disease that can turn human hands into virtual claws may be eased or even cured by a new injectable drug, a study suggests. The drug, called Xiaflex, could be an alternative to surgery for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback